Hello FPC crew,
Not to be confused with 2 Live Crew...Recently, a post appeared on another forum discounting radiation for oligometastatic patients with bone metastasis as having no survival benefit... The study that was listed used EBRT, so needless to say, it is important to understand the differences in types of radiation... I have posted a site with a simplified explanation of types of radiation...see below:
targetingcancer.com.au/radi...
As you can see, there is a difference and SBRT is a newer form of radiation treatment that is still under research. What the ORIOLE trial did find was that there was an "abscopal effect" from treatment with SBRT and that those that had no untreated lesions based on a PSMA scan were much less likely to have recurrence. Another article about the ORIOLE Trial:
grandroundsinurology.com/pc...
And, of course, there is my prior post on the ORIOLE Trial which people can refer back to in regards to reviewing the trial...see below:
healthunlocked.com/fight-pr...
Calling SBRT as "whack a mole" and having no survival benefit is inappropriate... SBRT is newer and it will be some time for determination of survival benefit... What I do know is that my MO is following about 80 cases similar to mine with "hitting it hard" with initial ADT and Zytiga as well as SBRT to oligometastatic lesions, getting to "undetectable" status and staying there, and watching them going on ADT vacations. Even if there was "no survival benefit" which is not something ANYONE can say, there is the matter of QOL and not experiencing "brain fog" or "hot flashes" or gaining weight or the risks of bone deterioration, heart disease, and prolonging the period to castrate resistance. Can anyone put a value on those issues because I can not...
At any rate, I welcome questions and comments...
Don Pescado